It looks like another fallen angle, ACTC an OTCBB company has been issued the E. The can be issued for a few reasons, but mainly for late filing. Some companies are able to complete...
Advanced Cell Technology, Inc. (OTCBB: ACTC) announced today that
Jonathan H. Dinsmore Ph.D., Senior Vice President –
Regulatory and Clinical, has been invited to present to the...
Program Highlights Accomplishments of Company’s
Chief Scientific Officer and Blastomere Program
Advanced Cell Technology, Inc. (OTCBB: ACTC) announced today that an ABC
...
Company Continues to Leverage IP Portfolio
Advanced Cell Technology, Inc. (OTCBB:ACTC) announced today that it has entered into an agreement with Pharming Group N.V. giving Pharming an...
Company Makes Progress on Multiple Therapeutic Fronts
Advanced Cell Technology, Inc. (OTCBB: ACTC) reported today for the first time a robust and highly efficient process for the...
Study Results Demonstrate Long Term Cell Survival and Quality of Life Improvements
Advanced Cell Technology, Inc. (OTCBB: ACTC - Stock message board forum) announced today that principal...
Company Demonstrates Progress Toward Moving its Second Cell Therapy
into Human Clinical Trials
Advanced Cell Technology, Inc. (OTCBB:ACTC stock forums) today announced...
DALLAS, Jan. 14 /PRNewswire/ -- Beacon Equity Research announces the
availability of TraderNotes on stocks that are making news today.
Investors can...
-New process Improves Efficiency to Levels Reported in
the Conventional Stem Cell Derivation Techniques-
Advanced Cell Technology, Inc. (OTC Bulletin Board: ACTC Stock...
Executive to Discuss Company’s Retinal Program and Recent Industry Issues
Advanced Cell Technology, Inc. (OTCBB: ACTC) announced today that William M. Caldwell, IV, the company’s Chief...
Advanced Cell Technology, Inc. (OTCBB: ACTC)
announced today that it has appointed Jonathan H. Dinsmore, Ph.D. to the
position of Senior Vice President - Regulatory and Clinical...
#60: NIH Announces Advanced Cell Technology's 'Single Cell Embryo Biopsy Technique' as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
ACT Applauds NIH Plan to Implement President Bush's Stem Cell Executive Order
LOS ANGELES, Sept. 20 /PRNewswire-FirstCall/ -- (OTC Bulletin Board: ACTC investing forum) On Tuesday, September 18,...
#59: ACTC News Advanced Cell's Robert Lanza, M.D. Will Speak on 'Promise: The Future of Stem Cells' Wednesday, March 28, 2007 at 7:30 PM at Quinnipiac University in Hamden, CT, Presented by StemConn 2007
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) Robert Lanza, M.D., VP of Research and Scientific Development, will participate in a panel...
#58: ACTC News Advanced Cell's Michael D. West, Ph.D., to Speak at 3rd Annual Stem Cell Research and Therapeutics Summit on ``Strategies for the Accelerated Development of Therapeutics from hES Cells''
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) Michael D. West, Ph.D., President and Chief Scientific Officer, will discuss “Strategies for...
ALAMEDA, Calif.--(BUSINESS WIRE)--Preclinical studies using hESCs derived from Advanced Cell Technology, Inc.’s (OTCBB: ACTC) proprietary ACTcellerate technology (a means of...